Just a moment, the page is loading...
The Supported Studies Programme

Specialty



Timelines





[Chronic Hepatitis B (CHB) Supported Studies Committee. Last updated in May 2026]
•   Understanding low diagnosis rates in CHB, impact to outcomes and opportunities to improve.
•   Measuring the impact of a functional cure on the risk of hepatitis B virus (HBV) transmission.
•   Understanding the impact of functional cure in subpopulations in chronic hepatitis B at greatest need for improved outcomes (e.g. those at most risk for hepatocellular carcinoma).
•   Optimizing the long-term management and monitoring of patients who have achieved functional cure.




© 2001-2026 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.